Isomorphic lands deals with Lilly, Novartis worth nearly $3B
Just more than two years after launching within Alphabet, Isomorphic has inked two large pharma deals with Eli Lilly and Novartis with nearly $3 billion in combined deal value. | Just more than two years after launching within Alphabet, Isomorphic has inked two large pharma deals with Eli Lilly and Novartis with nearly $3 billion in combined deal value.
Max Bayer Fierce Biotech
Health Tech Fierce Biotech
Fierce Biotech News & Reports
Google's AI Spin-Off Isomorphic Labs Strikes Big Pharma Deals, Paving the Way for Future of Drug Discovery - Alphabet (NASDAQ:GOOG), Alphabet (NASDAQ:GOOGL), Eli Lilly (NYSE:LLY), Novartis (NYSE:NVS) - Benzinga
Michael Jackson on LinkedIn: #tech #technology #innovation #deeptech #ai #artificialintelligence…
Steve Harvey on LinkedIn: Zoom interview tips
MedTech News - Medical Innovation Exchange
Fierce Biotech News & Reports
Max Bayer Fierce Biotech
Isomorphic lands deals with Lilly, Novartis worth nearly $3B
Health Tech Fierce Biotech
BioWorld: The Daily Biopharmaceutical News Source
Max Bayer Fierce JPM Week
